dr. udit verma on managing regorafenib side effects in crc
Published 8 years ago • 187 plays • Length 1:38Download video MP4
Download video MP3
Similar videos
-
1:46
dr. udit verma on regorafenib in patients with mcrc
-
4:28
proactive side effect management with regorafenib
-
1:12
dr. lenz on choosing between regorafenib and tas-102 in crc
-
6:33
patient selection for regorafenib in crc
-
11:24
managing toxicities associated with regorafenib
-
8:21
cancer is afraid of these products! top 15 cancer-destroying products
-
16:00
cancer warrior: my experience battling with cancer | amit jha | josh talks
-
2:33
what is prostate enlargement? | medicover hospitals
-
1:16
dr. eng on roles of regorafenib and tas-102 in crc treatment
-
1:21
dr. george demetri explains the side effects associated with regorafenib
-
5:31
practical advice for using regorafenib
-
3:53
regorafenib in colorectal cancer: optimizing the dose
-
4:14
the use of regorafenib in clinical practice
-
2:58
treatment response and side effects with regorafenib
-
3:14
when you have decided to prescribe regorafenib
-
3:54
colorectal cancer: patient follow-up with regorafenib
-
2:08
dr. becerra discusses regorafenib dosing in metastatic crc
-
3:48
clinical experience with regorafenib in hcc
-
1:28
dr. o’connor on real-world results with regorafenib in mcrc
-
1:20
dr. bekaii-saab on the use of regorafenib in patients with mcrc
-
0:58
dr. kim reviews studies investigating regorafenib in mcrc
-
5:32
colorectal cancer: regorafenib patient selection and dosing